Alex Chang, MD
banner
alexchangmd.bsky.social
Alex Chang, MD
@alexchangmd.bsky.social
Associate professor, clinician-scientist/dad/husband interested in early prevention/treatment of kidney disease
tweets=personal views #nephsky
Reposted by Alex Chang, MD
Yes. This is a game changer. Beyond being able to replace AVS, it allows one to “see” the underlying pathological contributors to a large proportion of “idiopathic” hypertension. This is another piece of evidence that should make clinicians rethink the pathogenesis and treatment of hypertension
November 28, 2025 at 6:05 PM
Seriously dumb policy.
November 25, 2025 at 3:00 PM
One final is definitely not final
November 19, 2025 at 7:38 PM
Reposted by Alex Chang, MD
I think Aliza Thompson is an unsung hero in this story for spearheading the albuminuria acceptance at FDA

journals.lww.com/cjasn/pages/...

#NephJC
journals.lww.com
November 19, 2025 at 3:00 AM
💯 deserves a ton of credit for moving things forward
November 19, 2025 at 3:39 AM
will get my excellent genetic counselor to work on it!
November 10, 2025 at 2:13 PM
Been awhile but found it! Col4a5 c.231 +2T>C
November 10, 2025 at 3:05 AM
Ah makes sense…working on a one-pager for patients in this setting. Strangely, colleague had a male in 30s with col4a5 asymptomatic without hematuria and proteinuria, normal GFR, detected on reproductive screening genetic test done prior to marriage
November 9, 2025 at 11:30 PM
Looked pretty mid
November 8, 2025 at 6:05 PM
Are you seeing asymptomatic prospective parents that have COL4A5?
November 8, 2025 at 11:19 AM